Papaverine Hydrochloride/Alprostadil/Phentolamine Mesilate

盐酸罂粟碱/前列地尔/甲磺酸酚妥拉明

Report date: 2026/02/05 15:08:45

Base Information

Drug NamePapaverine Hydrochloride/Alprostadil/Phentolamine Mesilate
Drug Alias NameStandro
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors antagonists3',5'-cyclic phosphodiesterase inhibitorsProstaglandin agonists +[4] 
TargetsDopamine receptors3',5'-cyclic phosphodiesteraseProstaglandin +[4] 
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsErectile Dysfunction
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date1999/11/06
Country/TerritorySouth Korea
CombinationsYes Papaverine HydrochlorideAlprostadilPhentolamine Mesilate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesShin Poong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShin Poong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A